Hikma Pharmaceuticals USA has started work on a $1 billion investment that includes an expansion of its West Side facilities. The company, a division of London-based Hikma, officially broke ground ...
Hikma Pharmaceuticals USA will invest $1 billion by 2030 to further expand its U.S. manufacturing and R&D capabilities. This new phase of investment -- America Leans on Hikma: Quality Medicines ...
May 8 (Reuters) - Hikma Pharmaceuticals (HIK.L), opens new tab has agreed to pay $50 million to settle a class action accusing the drugmaker of scheming to delay a generic version of Jazz’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results